Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accessory Structures of the Skin: Hair Growth and Types01:20

Accessory Structures of the Skin: Hair Growth and Types

2.8K
Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...
2.8K
Accessory Structures of the Skin: Hair and Hair Follicles01:16

Accessory Structures of the Skin: Hair and Hair Follicles

5.1K
Hair and hair follicles are integral components of the integumentary system. Hair is a filamentous structure composed mainly of a protein called keratin. It is found on the surface of the skin throughout the body, except for areas such as the palms of the hands and soles of the feet.
Hair is a keratinous filament growing out of the epidermis. It is primarily made of dead, keratinized cells. Hair strands originate at the epidermal penetration called the hair follicle. The hair shaft is the part...
5.1K
Infertility in Females01:28

Infertility in Females

5.0K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
5.0K
Multipotency and Niche of Bulge Stem Cell01:06

Multipotency and Niche of Bulge Stem Cell

4.3K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
4.3K
Folliculogenesis01:20

Folliculogenesis

3.0K
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
3.0K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

3.6K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose isotretinoin for difficult-to-treat rosacea: Enough evidence to be convinced-What's next?

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

You wait ages, and then two arrive at once: reporting guidelines should not be like buses.

Journal of clinical epidemiology·2025
Same author

Developing reporting checklist items from systematic review findings: a roadmap and lessons to be learned from ACCORD.

Journal of clinical epidemiology·2024
Same author

Tuning up the chords of consensus research with the ACcurate COnsensus Reporting Document (ACCORD).

The British journal of dermatology·2024
Same author

ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: Guidance and examples to support reporting consensus methods.

PLoS medicine·2024
Same author

Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.

JAMA dermatology·2024
Same journal

GLP-1 Receptor Agonists in Hidradenitis Suppurativa-Emerging Opportunities for Comorbidity Management?

JAMA dermatology·2026
Same journal

Topical Preparations for Moderate to Severe Rosacea Treatment: A Systematic Review and Network Meta-Analysis.

JAMA dermatology·2026
Same journal

GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa.

JAMA dermatology·2026
Same journal

BRAF Inhibition in Congenital Nevi and Neural Melanosis.

JAMA dermatology·2026
Same journal

The Absent Original in Smartphone Photography.

JAMA dermatology·2026
Same journal

A Tribute to a Master Clinician: Richard Odom.

JAMA dermatology·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.5K

Interventions for Female Pattern Hair Loss.

Esther J van Zuuren1, Zbys Fedorowicz2

  • 1Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.

JAMA Dermatology
|January 24, 2017
PubMed
Summary
This summary is machine-generated.

Topical minoxidil (2% and 5%) shows promise for treating female pattern hair loss (FPHL), with low- to moderate-quality evidence suggesting improvements. Other treatments like finasteride and laser devices had less consistent or negative findings regarding efficacy and safety for FPHL.

More Related Videos

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.8K
Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration
10:09

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

14.2K

Related Experiment Videos

Last Updated: Mar 8, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.5K
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.8K
Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration
10:09

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

14.2K

Area of Science:

  • Dermatology
  • Trichology
  • Evidence-Based Medicine

Background:

  • Female pattern hair loss (FPHP), also known as androgenetic alopecia, is a common condition causing progressive hair thinning in women.
  • Understanding effective and safe treatment options is crucial for managing FPHL and improving patient quality of life.

Purpose of the Study:

  • To systematically review and synthesize the evidence on the efficacy and safety of various interventions for treating female pattern hair loss (FPHL).
  • To provide clinicians and patients with a clear overview of the current evidence supporting different FPHL treatments.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials and other relevant studies evaluating interventions for FPHL.
  • Assessment of study quality using established criteria and synthesis of findings regarding hair growth, hair count, and adverse events.

Main Results:

  • Low- to moderate-quality evidence supports topical minoxidil (2% and 5%) for improving FPHL, with no significant increase in adverse events compared to placebo.
  • Low-quality evidence indicates finasteride is not more effective than placebo for FPHL.
  • Inconsistent results were observed for laser devices, although some studies showed increased total hair count compared to baseline (moderate- to low-quality evidence).
  • Most evaluated treatments demonstrated comparable adverse event rates to placebo.

Conclusions:

  • Topical minoxidil is a recommended first-line treatment for FPHL, supported by moderate-quality evidence.
  • Finasteride lacks sufficient evidence for efficacy in FPHL treatment.
  • Laser therapy shows potential but requires further high-quality research to confirm its effectiveness and safety profile for FPHL.